Motus gi announces warrant exercise agreement resulting in expected gross proceeds to the company of up to $11 million

Fort lauderdale, fla., jan. 27, 2021 (globe newswire) -- motus gi holdings, inc., (nasdaq: mots) (“motus gi” or the “company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that it has signed a warrant exercise agreement with an existing institutional investor that is expected to provide the company with gross proceeds of up to $11.0 million.
MOTS Ratings Summary
MOTS Quant Ranking